Pharmaceutical Contract Manufacturing - Global Market Trends

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.MARKET DYNAMICS
An Insight into the Rise of PCM
Industry Potential
3.SERVICE OVERVIEW
Introduction
Injectables (injections, vials, and IV solutions)
Solid Dosage Forms (SDFs) (Tablets and Capsules)
Liquid Dosage Forms (LDFs) (Syrups and Suspensions)
A Focus on Bio-Manufacturing
4.TRENDS AND ISSUES
Outsourcing Emerges as a Strategic Priority for Pharmaceutical Companies
Asia Dominates Regional Growth, North America Retains Position as Largest Market
Virtual Pharma vs. Blockbuster Model
Investment Risks in Pharmaceutical Contract
Quality Assurance Risk
Drug Development Risk
Acquisition Risk
Client Dependency Risk
5.CORPORATE DEVELOPMENTS
Jubilant Acquires Draxis for US$ 253 Million
JHP Acquires Assets of King Pharmaceuticals
NextPharma Acquires Bioserv Corporation
Dr. Reddy’s to Acquire Dowpharma’s Facilities
PharmAthene to Acquire Avecia’s Biodefense Vaccine Operations
Bioserv Enters into an Outsourcing Agreement with BioLife Solutions
Eden Biodesign and Stealthyx Therapeutics Ink an Agreement
NPIL Pharma to Expand HPS Sites in Scotland
Dishman Pharma Installs New API Facilities
Patheon Divests Niagara-Burlington Manufacturing Business to Pharmetics
Jubilant Organosys Acquires Hollister-Stier Laboratories
Hikma Pharmaceuticals Acquires Thymoorgan GmbH Pharmazie
Meda Acquires Recip
Keata Pharma to Acquire Pfizer’s Production Facility in Canada
STADA Acquires MAKIZ
Nextpharma to Expand its Cytostatics Production Facility
Haupt Pharma Establishes Production Facility in Malta
6.MAJOR PLAYERS
Althea Technologies (USA)
Catalent Pharma Solutions (USA)
Dishman Pharmaceuticals and Chemicals Ltd (India)
HAUPT Pharma AG (Germany)
Jubilant Organosys Ltd (India)
Kemwell Pvt. Ltd (India)
NextPharma (UK)
Nipro Corp (Japan)
Patheon, Inc. (Canada)
Penn Pharmaceutical Services Ltd (UK)
Royal DSM N.V. (Netherlands)
7.MARKET ANALYTICS
8.THE UNITED STATES
Trends
Pharma Companies Increasingly Outsource Manufacturing Activity
Injectables Segment Witnesses Upward Growth Trend
Competitive Landscape
9.CANADA
10.JAPAN
Impact of Contract Manufacturing on Japanese Pharmaceutical Sector
11.EUROPE
Trend
Injectables Segment Offers Promising Potential
Competitive Scenario
12.ASIA-PACIFIC
Trends
Upbeat Market for Pharmaceutical Contract Manufacturing
Competitive Scenario
India
13.REST OF WORLD
Exhibits
Table 1: Global Markets for Pharmaceutical Contract Manufacturing by Region for the Period 2007-2015 (Sales in US$ Million)
Table 2: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing by Region for the Years 2008 & 2009
Table 3: Global Markets for Pharmaceutical Contract Manufacturing of Injectables by Region for the Period 2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Injectables by Region for the Years 2008 & 2009
Table 5: Global Markets for Pharmaceutical Contract Manufacturing of Solid Dosage Forms by Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Solid Dosage Forms by Region for the Years 2008 & 2009
Table 7: Global Markets for Pharmaceutical Contract Manufacturing of Liquid Dosage Forms by Region for the Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Liquid Dosage Forms by Region for the Years 2008 & 2009
Table 9: Pharmaceutical Contract Manufacturing Market by Product Segment in the US: 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in the US for the Years 2008 & 2009
Table 11: Pharmaceutical Contract Manufacturing Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Canada for the Years 2008 & 2009
Table 13: Pharmaceutical Contract Manufacturing Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Japan for the Years 2008 & 2009
Table 15: Pharmaceutical Contract Manufacturing Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Europe for the Years 2008 & 2009
Table 17: Pharmaceutical Contract Manufacturing Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 18: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Asia-Pacific for the Years 2008 & 2009
Table 19: Pharmaceutical Contract Manufacturing Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Rest of World for the Years 2008 & 2009
Companies Profiled